KalVista Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
55 Cambridge Parkway, Suite 901 E, Cambridge, MA
State of incorporation
DE
Fiscal year end
April 30
Data updated at
12/5/2024, 04:08 PM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Nov 7, 2024
SC 13D/A Report SC 13D/A Apr 1, 2024
SC 13D/A Report SC 13D/A Feb 22, 2024
SC 13D/A Report SC 13D/A Feb 20, 2024
SC 13D/A Report SC 13D/A Dec 14, 2023
SC 13D Report SC 13D Jan 9, 2023
SC 13D/A Report SC 13D/A Dec 30, 2022
SC 13D/A Report SC 13D/A Feb 10, 2022
SC 13D/A Report Jan 31, 2022
SC 13D Report ACQUISITION OF BENEFICIAL OWNERSHIP Dec 30, 2021
SC 13D/A Report SC 13D/A Feb 16, 2021
SC 13D/A Report SC 13D/A Apr 24, 2019
SC 13D/A Report SCHEDULE 13D AMENDMENT NO. 2 Apr 15, 2019
SC 13D/A Report SC 13D/A Apr 3, 2019
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 3) Mar 20, 2019
SC 13D/A Report SCHEDULE 13D/A (AMENDMENT NO. 2) Feb 26, 2019
SC 13D/A Report SC 13D/A Nov 13, 2017
SC 13D Report SC 13D Oct 20, 2017
SC 13D/A Report SC 13D/A Oct 13, 2017
SC 13D/A Report SC 13D/A Sep 22, 2017
SC 13D/A Report SC 13D/A Mar 2, 2017
SC 13D Report SC 13D Feb 14, 2017
SC 13D/A Report SC 13D/A Feb 13, 2017
SC 13D Report SC 13D Feb 7, 2017
SC 13D Report SC 13D Nov 30, 2016
SC 13D Report SC 13D Jun 27, 2016
SC 13D/A Report SC 13D/A Jun 24, 2016
SC 13D/A Report SC 13D/A Jun 23, 2016
SC 13D Report CARBYLAN THERAPEUTICS SCHEDULE 13D 4-24-15 Apr 24, 2015
SC 13D Report SCHEDULE 13D Apr 24, 2015
SC 13D Report SC 13D Apr 21, 2015